T. Patel, Cholangiocarcinoma???controversies and challenges, Nature Reviews Gastroenterology & Hepatology, vol.220, issue.4, pp.189-200, 2011.
DOI : 10.1038/nrgastro.2011.20

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888819

S. Taylor-robinson, M. Toledano, and S. Arora, Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998, Gut, vol.48, issue.6, pp.816-820, 2001.
DOI : 10.1136/gut.48.6.816

T. Patel, Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States, Hepatology, vol.33, issue.6, pp.1353-1357, 2001.
DOI : 10.1053/jhep.2001.25087

T. Welzel, B. Graubard, and H. Eleserag, Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma in the United States: A Population-Based Case-Control Study, Clinical Gastroenterology and Hepatology, vol.5, issue.10, pp.1221-1228, 2007.
DOI : 10.1016/j.cgh.2007.05.020

R. Wood, D. Brewster, L. Fraser, H. Brown, P. Hayes et al., Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland, European Journal of Cancer, vol.39, issue.14, pp.2087-2092, 2003.
DOI : 10.1016/S0959-8049(03)00544-6

L. Sulpice, M. Rayar, E. Boucher, M. Pracht, B. Meunier et al., Treatment of recurrent intrahepatic cholangiocarcinoma, British Journal of Surgery, vol.166, issue.12, pp.1711-1717, 2012.
DOI : 10.1002/bjs.8953

URL : https://hal.archives-ouvertes.fr/inserm-00865290

T. Terada, K. Makimoto, N. Terayama, Y. Suzuki, and Y. Nakanuma, Alpha-smooth muscle actin-positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomas, J Hepatol, vol.24, pp.706-712, 1996.

K. Kajiyama, T. Maeda, K. Takenaka, K. Sugimachi, and M. Tsuneyoshi, The Significance of Stromal Desmoplasia in Intrahepatic Cholangiocarcinoma, The American Journal of Surgical Pathology, vol.23, issue.8, pp.892-902, 1999.
DOI : 10.1097/00000478-199908000-00006

A. Sirica, The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma, Nature Reviews Gastroenterology & Hepatology, vol.25, issue.1, pp.44-54, 2012.
DOI : 10.1038/nrgastro.2011.222

D. Hanahan and R. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011.
DOI : 10.1016/j.cell.2011.02.013

L. Sulpice, M. Rayar, and M. Desille, Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma, Hepatology, vol.28, issue.6, 2013.
DOI : 10.1002/hep.26577

URL : https://hal.archives-ouvertes.fr/hal-01068717

C. Coulouarn, A. Corlu, D. Glaise, I. Gué-non, and S. Thorgeirsson, Hepatocyte-Stellate Cell Cross-Talk in the Liver Engenders a Permissive Inflammatory Microenvironment That Drives Progression in Hepatocellular Carcinoma, Cancer Research, vol.72, issue.10, pp.2533-2542, 2012.
DOI : 10.1158/0008-5472.CAN-11-3317

URL : https://hal.archives-ouvertes.fr/inserm-00864206

C. Wong, A. Tse, and Y. Huang, Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma, Hepatology, vol.20, issue.5, pp.1645-1658, 2014.
DOI : 10.1002/hep.27320

H. Kagan and W. Li, Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell, Journal of Cellular Biochemistry, vol.262, issue.4, pp.660-672, 2003.
DOI : 10.1002/jcb.10413

V. Barry-hamilton, R. Spangler, and D. Marshall, Allosteric inhibition of lysyl oxidase???like-2 impedes the development of a pathologic microenvironment, Nature Medicine, vol.117, issue.9, pp.1009-1017, 2010.
DOI : 10.1038/nm.2208

S. Fong, E. Dietzsch, and K. Fong, Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors, Genes, Chromosomes and Cancer, vol.24, issue.7, pp.644-655, 2007.
DOI : 10.1002/gcc.20444

S. Ahn, S. Dong, and A. Oshima, LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients, Breast Cancer Research and Treatment, vol.125, issue.1, pp.89-99, 2013.
DOI : 10.1007/s10549-013-2662-3

M. Wilgus, A. Borczuk, and M. Stoopler, Lysyl oxidase: A lung adenocarcinoma biomarker of invasion and survival, Cancer, vol.4, issue.3 suppl, pp.2186-2191, 2011.
DOI : 10.1002/cncr.25768

T. Schmittgen and K. Livak, Analyzing real-time PCR data by the comparative CT method, Nature Protocols, vol.2, issue.6, pp.1101-1108, 2008.
DOI : 10.1038/nprot.2008.73

D. Sia, Y. Hoshida, and A. Villanueva, Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes, Gastroenterology, vol.144, issue.4, pp.829-840, 2013.
DOI : 10.1053/j.gastro.2013.01.001

J. Andersen, B. Spee, and B. Blechacz, Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors, Gastroenterology, vol.142, issue.4, pp.1021-1031, 2012.
DOI : 10.1053/j.gastro.2011.12.005

G. Moreno-bueno, F. Salvador, and A. Martín, Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas, EMBO Molecular Medicine, vol.6, issue.9, pp.528-544, 2011.
DOI : 10.1002/emmm.201100156

L. Peng, Y. Ran, and H. Hu, Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway, Carcinogenesis, vol.30, issue.10, pp.1660-1669, 2009.
DOI : 10.1093/carcin/bgp178

H. Peinado, G. Moreno-bueno, and D. Hardisson, Lysyl Oxidase-Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas, Cancer Research, vol.68, issue.12, pp.4541-4550, 2008.
DOI : 10.1158/0008-5472.CAN-07-6345

D. Abourbih, D. Cesare, S. Orellana, and M. , Lysyl oxidase expression and inhibition in uveal melanoma, Melanoma Research, vol.20, issue.2, pp.97-106, 2010.
DOI : 10.1097/CMR.0b013e328336edfe

M. Pickup, H. Laklai, and I. Acerbi, Stromally Derived Lysyl Oxidase Promotes Metastasis of Transforming Growth Factor-??-Deficient Mouse Mammary Carcinomas, Cancer Research, vol.73, issue.17, pp.5336-5346, 2013.
DOI : 10.1158/0008-5472.CAN-13-0012

M. Mueller and N. Fusenig, Friends or foes ??? bipolar effects of the tumour stroma in cancer, Nature Reviews Cancer, vol.22, issue.11, pp.839-849, 2004.
DOI : 10.1038/nrc1477

H. Kasashima, M. Yashiro, and H. Kinoshita, Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer, Cancer Letters, vol.354, issue.2, pp.438-446, 2014.
DOI : 10.1016/j.canlet.2014.08.014

A. Cano, P. Santamaría, and G. Moreno-bueno, LOXL2 in epithelial cell plasticity and tumor progression, Future Oncology, vol.8, issue.9, pp.1095-1108, 2012.
DOI : 10.2217/fon.12.105